作者:
Petersenn,S. [1]
;
Farrall,A.J. [2]
;
DeBlock,C. [3]
;
Melmed,S. [4]
;
Schopohl,J. [5]
;
Caron,P. [6]
;
Cuneo,R. [7]
;
Kleinberg,D. [8]
;
Colao,A. [9]
;
Ruffin,M. [10]
;
HermosilloReséndiz,K. [11]
;
Hughes,G. [12]
;
Hu,K. ;
Barkan,A.
作者单位:
Neuroendocrine Unit, New York University School of Medicine, New York, NY, United States
[1]
Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, QLD, Australia
[2]
Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy
[3]
Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerp
[4]
Novartis Pharmaceuticals, East Hanover, NJ, United States
[5]
Pituitary and Neuroendocrine Center, University of Michigan, Ann Arbor, MI, United States
[6]
Service d'Endocrinologie, Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire
[7]
ENDOC Center for Endocrine Tumors, Altonaer Str. 59, 20357 Hamburg, Germany
[8]
Novartis Pharma AG, Basel, Switzerland
[9]
Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA, United
[10]
Medizinische Klinik und Poliklinik IV, Campus Innenstadt, University of Munich, Munich, Germany
[11]
Brain Research Imaging Centre, Western General Hospital, University of Edinburgh, Edinburgh, United
[12]
发布时间
2014-05-21